Infectious diseases Archives - Page 13 of 15

Efficacy and safety of photodynamic therapy with RLP068 for diabetic foot ulcers: a review of the literature and clinical experience

Felicia Pantò MD, Liboria Adamo BSc, Carla Giordano MD, Carmelo Licciardello MD

Article Type

Review

Published

10 Feb 2020

This is the second part of a literature review concerning diabetic foot ulcers (DFUs) and the use of antimicrobial photodynamic therapy (PDT). It focuses on the Zn(II)phthalocyanine derivative RLP608.

Challenges and research priorities to progress the impact of antimicrobial stewardship

Matteo Bassetti MD, PhD, Daniele Roberto Giacobbe MD, Antonio Vena MD, PhD, Adrian Brink MMed

Article Type

Review

Published

19 Aug 2019

This review discusses and explains the most important challenges faced by antibiotic stewardship and antifungal stewardship programmes and suggests areas for further research.

Oral oncolytic and antiretroviral therapy administration: dose adjustments, drug interactions, and other considerations for clinical use

Melissa E Badowski PharmD, MPH, Bradley Burton PharmD, Kristy M Shaeer PharmD, MPH, John Dicristofano BS, PharmD Candidate

Article Type

Review

Published

13 Feb 2019

This article evaluates existing literature through such means as drug databases and package inserts along with PubMed/Medline, Embase, and Google Scholar databases to develop a reference tool for providers to utilize when there is a decision to treat a patient with ART and oral oncolytic agents concurrently.

Penile warts: an update on their evaluation and management

Alexander KC Leung MBBS, FRCPC, FRCP (UK and Irel), FRCPCH, FAAP, Benjamin Barankin MD, FRCPC, Kin Fon Leong MBBS, MRCPCH, Kam Lun Hon MD, FAAP, FCCM

Article Type

Review

Published

19 Dec 2018

This articles provides an update on the current understanding, evaluation, and management of penile warts.

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs

Pedro Luis Gonzalez MD, MT, Urania Rappo MD, Karthik Akinapelli MS, Jennifer S McGregor RPh, Sailaja Puttagunta MD, Michael W Dunne MD

Article Type

Original Research

Published

11 Dec 2018

This subgroup analysis sought to more fully characterize the demographics, baseline characteristics, safety, and efficacy of
dalbavancin in the persons who inject drugs (PWID) and non-PWID population and as a single-dose therapy versus 2-dose therapy from a previously published global trial.